Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SASR
13026
CALL
DELISTED
Sandy Spring Bancorp Inc
SASR
| $23.6K | ﹤0.01% |
700
-2,400
| -77% | -$83.8K |
|
13027
PUT
ProShares UltraShort FTSE China 50 of ProShares Trust
FXP
$6.24M
| $23.6K | ﹤0.01% |
+650
| New | +$23.5K |
|
13028
CALL
Janus International
JBI
$697M
| $23.5K | ﹤0.01% |
3,200
+100
| +3% | +$825 |
|
|
13029
PUT
Janus International
JBI
$697M
| $23.5K | ﹤0.01% |
3,200
-2,900
| -48% | -$23.9K |
|
|
TIRX
13030
DELISTED
Tian Ruixiang Holdings
TIRX
| $23.5K | ﹤0.01% |
+2,747
| New | +$24.4K |
|
13031
BiomX
PHGE
$1.59M
| $23.5K | ﹤0.01% |
+1,692
| New | +$24.1K |
|
|
TOPT
13032
PUT
iShares Top 20 U.S. Stocks ETF
TOPT
$679M
| $23.5K | ﹤0.01% |
+900
| New | +$23.1K |
|
13033
PUT
Nu Skin
NUS
$234M
| $23.4K | ﹤0.01% |
3,400
-4,100
| -55% | -$28.2K |
|
13034
PUT
Invesco High Yield Equity Dividend Achievers ETF
PEY
$1.18B
| $23.4K | ﹤0.01% |
1,100
+1,000
| +1,000% | +$22K |
|
13035
CALL
VanEck Steel ETF
SLX
$173M
| $23.4K | ﹤0.01% |
400
-1,300
| -76% | -$88.1K |
|
13036
GEE Group
JOB
$27M
| $23.4K | ﹤0.01% |
112,940
-111,942
| -50% | -$27.7K |
|
13037
Ampco-Pittsburgh
AP
$194M
| $23.4K | ﹤0.01% |
+11,182
| New | +$21.3K |
|
13038
CALL
Cognyte Software
CGNT
$674M
| $23.4K | ﹤0.01% |
2,700
-19,900
| -88% | -$150K |
|
13039
CALL
Century Casinos
CNTY
$36M
| $23.3K | ﹤0.01% |
7,200
-1,700
| -19% | -$5.97K |
|
13040
CALL
Wrap Technologies
WRAP
$105M
| $23.3K | ﹤0.01% |
11,000
-119,300
| -92% | -$196K |
|
|
JFU
13041
9F Inc
JFU
$26.3M
| $23.3K | ﹤0.01% |
+14,827
| New | +$24.9K |
|
13042
CALL
Zura Bio
ZURA
$534M
| $23.3K | ﹤0.01% |
9,300
+7,300
| +365% | +$26K |
|
13043
ZK International Group
ZKIN
$60.8M
| $23.2K | ﹤0.01% |
+5,530
| New | +$22.9K |
|
13044
CALL
Westwood Holdings Group
WHG
$186M
| $23.2K | ﹤0.01% |
+1,600
| New | +$24.6K |
|
13045
CALL
Vor Biopharma
VOR
$1.36B
| $23.2K | ﹤0.01% |
1,045
+580
| +125% | +$9.61K |
|
13046
CALL
Amplify Mobile Payments ETF
IPAY
$188M
| $23.2K | ﹤0.01% |
+400
| New | +$22.9K |
|
13047
CALL
American Vanguard Corp
AVD
$62.5M
| $23.1K | ﹤0.01% |
5,000
-35,300
| -88% | -$191K |
|
13048
Acuity Brands
AYI
$10.7B
| $23.1K | ﹤0.01% |
79
-99,878
| -100% | -$31.2M |
|
13049
CALL
Gray Television
GTN
$538M
| $23K | ﹤0.01% |
7,300
-52,000
| -88% | -$243K |
|
13050
CALL
Mizuho Financial
MFG
$132B
| $23K | ﹤0.01% |
4,700
+4,200
| +840% | +$19.4K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.